This increase in the IFN-γ+ CD4 and CD8 T-cell proportion suggests that IRT may enhance relative T-cell function acting in the pro-inflammatory cell-mediated Th1 response, making SAD patients better able to respond to infection through IRT immunomodulation. The gene discussed is IFNG; the disease is infection.